PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 29849046-5 2018 In the present study, a novel, gel-formulated, first-in-class small-molecule inhibitor of GzmB, VTI-1002, was assessed in a murine model of impaired, diabetic burn wound healing. vti-1002 96-104 granzyme B Mus musculus 90-94